2022
Health Economics Research in Cancer Treatment: Current Challenges and Future Directions
Yu J, Schrag D, Yabroff K. Health Economics Research in Cancer Treatment: Current Challenges and Future Directions. JNCI Monographs 2022, 2022: 51-56. PMID: 35788370, DOI: 10.1093/jncimonographs/lgac009.Peer-Reviewed Original ResearchConceptsHealth economics researchMeasures of social determinants of healthCancer health economics researchNational Cancer Institute's Division of Cancer Control and Population SciencesSocial determinants of healthCost of cancer careDivision of Cancer Control and Population SciencesDeterminants of healthHealth-care systemStudies of cancer treatmentCancer treatmentCancer careIntegration of economic analysisInsurance typeHealth economistsPopulation scienceProspective economic studyHealthArea of focusWorkgroupStandard evaluationEconomic researchCancerCareClinical trials
2019
Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper
Hayman J, Dekker A, Feng M, Keole S, McNutt T, Machtay M, Martin N, Mayo C, Pawlicki T, Smith B, Kudner R, Dawes S, Yu J. Minimum Data Elements for Radiation Oncology: An American Society for Radiation Oncology Consensus Paper. Practical Radiation Oncology 2019, 9: 395-401. PMID: 31445187, DOI: 10.1016/j.prro.2019.07.017.Peer-Reviewed Original ResearchConceptsElectronic health record vendorsData elementsImprove care coordinationElectronic health recordsMinimum data elementsCare coordinationPractice staffHealth recordsRadiation oncology dataIncident learning systemAccreditation programASTRO Board of DirectorsData entryTask ForceQuality measuresAmerican Society for Radiation Oncology (ASTRODraft manuscriptRegistryDatabase architectInteroperability initiativesLegal counselLearning systemCancer treatmentHolistic approachRadiation oncology
2017
Use of alternative medicine for cancer and its impact on survival.
Johnson S, Gross C, Park H, Yu J. Use of alternative medicine for cancer and its impact on survival. Journal Of Clinical Oncology 2017, 35: e18175-e18175. DOI: 10.1200/jco.2017.35.15_suppl.e18175.Peer-Reviewed Original ResearchCharlson-Deyo comorbidity scoreConventional cancer treatmentsNational Cancer DatabaseAlternative medicineColorectal cancerCancer treatmentComorbidity scoreCox proportional hazards regressionGreater riskNon-metastatic breastYear of diagnosisAlternative medicine useKaplan-Meier methodSubgroup of patientsAlternative medicine utilizationProportional hazards regressionCancer patient characteristicsDisease-related factorsLog-rank testAnti-cancer treatmentChi-square testPatterns of utilizationHigher socioeconomic statusHormone therapyOverall survival
2015
“The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative lung cancer treatment.
Presley C, Soulos P, Yu J, Gross C. “The burden upon me”: The complexity of healthcare utilization among Medicare patients undergoing curative lung cancer treatment. Journal Of Clinical Oncology 2015, 33: 7533-7533. DOI: 10.1200/jco.2015.33.15_suppl.7533.Peer-Reviewed Original Research
2014
Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer.
Delpe S, Shah N, Tilburt J, Karnes R, Nguyen P, Shuch B, Gross C, Schulam P, Yu J, Ziegenfuss J, Kim S. Perceptions of radiation oncologists and urologists on the type of evidence that informs and changes the clinical practice of prostate cancer. Journal Of Clinical Oncology 2014, 32: 167-167. DOI: 10.1200/jco.2014.32.4_suppl.167.Peer-Reviewed Original ResearchLevel of evidenceProstate cancerSpecialty-specific journalsRadiation oncologistsTreatment recommendationsClinical practiceClinical guidelinesMultivariable logistic regression modelLocalized prostate cancerNew treatment paradigmProstate cancer specialistsProstate cancer treatmentLogistic regression modelsNational survey studySurvey response ratePhysician characteristicsTreatment paradigmCancer specialistsResponse rateOncologistsUrologistsCancerCancer treatmentRCTsCancer journals
2013
Interpreting cost-utility analysis of prostate cancer treatment
Yu J. Interpreting cost-utility analysis of prostate cancer treatment. Nature Reviews Urology 2013, 10: 129-131. PMID: 23399726, DOI: 10.1038/nrurol.2013.17.Peer-Reviewed Original Research
2011
Are the Efforts of Current Clinical Trials Involving Radiation Therapy Focused on the Evidence Gaps in Cancer Treatment?
Lloyd S, Gross C, Makarov D, Yu J. Are the Efforts of Current Clinical Trials Involving Radiation Therapy Focused on the Evidence Gaps in Cancer Treatment? International Journal Of Radiation Oncology • Biology • Physics 2011, 81: s139-s140. DOI: 10.1016/j.ijrobp.2011.06.286.Peer-Reviewed Original Research